☆ 4.7 Article

Integrated Multi-Omics Analysis for Inferring Molecular Players in Inclusion Body Myositis

ANTIOXIDANTS (2023)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

Inclusion body myositis: from genetics to clinical trials

Sara Nagy et al.

Summary: Inclusion body myositis (IBM) is a slowly progressive idiopathic inflammatory myopathy characterized by asymmetric muscle weakness primarily affecting the finger flexors and knee extensors. Limited data exists on the genetic susceptibility of sporadic IBM, despite some genes being associated with hereditary IBM.

JOURNAL OF NEUROLOGY (2023)

Add to Collection

Article Geriatrics & Gerontology

Unravelling inclusion body myositis using a patient-derived fibroblast model

Judith Canto-Santos et al.

Summary: In this study, molecular disturbances were found in fibroblast samples from IBM patients, including abnormal gene expression related to inflammation, mitochondria, and cell cycle regulation, as well as functional changes in inflammatory, autophagy, mitochondrial, and metabolic processes. These findings contribute to a better understanding of the pathogenesis of IBM and provide insights for the identification of new biomarkers and therapeutic strategies.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2023)

Add to Collection

Article Clinical Neurology

Muscle Transcriptomics Shows Overexpression of Cadherin 1 in Inclusion Body Myositis

Chiseko Ikenaga et al.

Summary: This study explored the molecular features of inclusion body myositis (IBM) and found that the differentially expressed genes and pathways in IBM and polymyositis were mostly comparable. However, the pathways related to cell adhesion molecules were upregulated in IBM. The study also discovered the overexpression of the epidermal cell junction protein cadherin 1 in the muscles of IBM, which could provide valuable insights into the pathological mechanisms of IBM.

ANNALS OF NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

Immunophenotyping of Inclusion Body Myositis Blood T and NK Cells

Namita A. Goyal et al.

Summary: This study evaluated the therapeutic potential of targeting highly differentiated T cells in patients with inclusion body myositis (IBM) by establishing high-resolution mapping of killer cell lectin-like receptor subfamily G member 1 (KLRG1(+)) within the T and NK cell compartments. The results showed that KLRG1(+) Tem and TemRA populations were expanded in both CD4(+) and CD8(+) T-cell subpopulations in patients with IBM, indicating a potential target for therapy in IBM.

NEUROLOGY (2022)

Add to Collection

Article Cell Biology

Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis

Kyla A. Britson et al.

Summary: Sporadic inclusion body myositis (IBM) is the most common acquired muscle disease in adults over age 50, with recent research showing a link between the loss of TDP-43 protein in IBM muscle and disease development. A xenograft model established by transplanting human IBM muscle into mice demonstrated the involvement of T cells in the disease, yet depletion of T cells did not alter the degenerative pathology of IBM muscle.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Add to Collection

Article Rheumatology

The role of protein aggregation in the pathogenesis of inclusion body myositis.

Andrew M. Snedden et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2022)

Add to Collection

Article Rheumatology

Survival and associated comorbidities in inclusion body myositis

Elie Naddaf et al.

Summary: This study evaluated the survival and associated comorbidities in inclusion body myositis (IBM) patients. The results showed that IBM was associated with lower survival, and higher frequency of peripheral neuropathy, Sjogren's syndrome, and hematologic malignancies.

RHEUMATOLOGY (2022)

Add to Collection

Review Clinical Neurology

Inclusion body myositis: evolving concepts

Mari Perez-Rosendahl et al.

Summary: This review discusses recent developments in the understanding of epidemiology, diagnostics, biomarkers, pathology, pathogenesis, outcome measures, and therapeutics in inclusion body myositis (IBM). Recent epidemiology data confirms a higher prevalence in the population above 50 years old and a reduced life expectancy. The association with cancer and other systemic disorders is better defined. The role of magnetic resonance imaging (MRI) and ultrasound in diagnosis and disease progression has been elucidated. New blood and imaging biomarkers show promise for diagnosis and outcome measures in therapeutic trials. Improved understanding of the disease's pathogenesis will lead to better therapeutic interventions.

CURRENT OPINION IN NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

A network of core and subtype-specific gene expression programs in myositis

David R. Amici et al.

Summary: This study utilized muscle biopsy transcriptome data from myositis patients to construct a co-expression network of 8101 dynamically regulated transcripts, revealing key biological processes and disease signatures associated with myositis.

ACTA NEUROPATHOLOGICA (2021)

Add to Collection

Article Biochemistry & Molecular Biology

MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations

Sneha Rath et al.

Summary: MitoCarta3.0 is a catalog of over 1000 genes encoding the mammalian mitochondrial proteome, with 1136 human genes after manual review. It includes annotations of sub-mitochondrial localization and hierarchical 'MitoPathways', serving as a valuable resource for mitochondrial biology and medicine.

NUCLEIC ACIDS RESEARCH (2021)

Add to Collection

Review Rheumatology

Pathogenesis of inclusion body myositis

Steven A. Greenberg

CURRENT OPINION IN RHEUMATOLOGY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

The Impact of Mitochondrial Deficiencies in Neuromuscular Diseases

Judith Canto-Santos et al.

ANTIOXIDANTS (2020)

Add to Collection

Review Rheumatology

Inclusion body myositis: clinical features and pathogenesis

Steven A. Greenberg

NATURE REVIEWS RHEUMATOLOGY (2019)

Add to Collection

Article Clinical Neurology

Highly differentiated cytotoxic T cells in inclusion body myositis

Steven A. Greenberg et al.

BRAIN (2019)

Add to Collection

Article Clinical Neurology

Identification of distinctive interferon gene signatures in different types of myositis

Iago Pinal-Fernandez et al.

NEUROLOGY (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras

Boel De Paepe

BIOMOLECULES (2019)

Add to Collection

Article Clinical Neurology

Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer's disease dementia from normal controls: preliminary findings

Marwan N. Sabbagh et al.

BMC NEUROLOGY (2018)

Add to Collection

Review Clinical Neurology

Classification and management of adult inflammatory myopathies

Albert Selva-O'Callaghan et al.

LANCET NEUROLOGY (2018)

Add to Collection

Article Medicine, Research & Experimental

Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers

Jana Buzkova et al.

EMBO MOLECULAR MEDICINE (2018)

Add to Collection

Article Neurosciences

A Method for Diagnosing Alzheimer's Disease Based on Salivary Amyloid-β Protein 42 Levels

Moonhee Lee et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

Add to Collection

Article Clinical Neurology

Pathomechanisms of Anti-Cytosolic 5′-Nucleotidase 1A Autoantibodies in Sporadic Inclusion Body Myositis

Nozomu Tawara et al.

ANNALS OF NEUROLOGY (2017)

Add to Collection

Review Biotechnology & Applied Microbiology

Multi-omics approaches to disease

Yehudit Hasin et al.

GENOME BIOLOGY (2017)

Add to Collection

Article Medicine, Research & Experimental

Mitochondrial DNA disturbances and deregulated expression of oxidative phosphorylation and mitochondrial fusion proteins in sporadic inclusion body myositis

Marc Catalan-Garcia et al.

CLINICAL SCIENCE (2016)

Add to Collection

Review Clinical Neurology

Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken

Olivier Benveniste et al.

ACTA NEUROPATHOLOGICA (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Regulation of mammalian nucleotide metabolism and biosynthesis

Andrew N. Lane et al.

NUCLEIC ACIDS RESEARCH (2015)

Add to Collection

Review Immunology

Diagnosis and classification of sporadic inclusion body myositis (sIBM)

M. Catalan et al.

AUTOIMMUNITY REVIEWS (2014)

Add to Collection

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Add to Collection

Review Biochemistry & Molecular Biology

Glutathione and glutathione analogues; Therapeutic potentials

Jian Hui Wu et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)

Add to Collection

Article Biochemical Research Methods

STAR: ultrafast universal RNA-seq aligner

Alexander Dobin et al.

BIOINFORMATICS (2013)

Add to Collection

Review Toxicology

What is the clinical significance of 5-oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure?

D. B. Liss et al.

CLINICAL TOXICOLOGY (2013)

Add to Collection

Article Clinical Neurology

188th ENMC International Workshop: Inclusion Body Myositis, 2-4 December 2011, Naarden, The Netherlands

M. R. Rose

NEUROMUSCULAR DISORDERS (2013)

Add to Collection

Article Biochemical Research Methods

RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome

Bo Li et al.

BMC BIOINFORMATICS (2011)

Add to Collection

Article Clinical Neurology

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study

Felix Bermejo-Pareja et al.

BMC NEUROLOGY (2010)

Add to Collection

Review Biochemistry & Molecular Biology

Glutathione: Overview of its protective roles, measurement, and biosynthesis

Henry Jay Forman et al.

MOLECULAR ASPECTS OF MEDICINE (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.